Full text is available at the source.
Enterobacter aerogenes ZDY01 inhibits choline-induced atherosclerosis through CDCA-FXR-FGF15 axis
Enterobacter aerogenes ZDY01 may reduce artery plaque caused by choline through a specific liver-intestine signaling pathway
AI simplified
Abstract
ZDY01 reduced serum trimethylamine-oxide (TMAO) levels by decreasing cecal trimethylamine (TMA) in ApoE mice fed with 1.3% choline.
- ZDY01 inhibited choline-induced atherosclerosis in ApoE mice.
- The treatment decreased cecal TMA and serum TMAO levels by utilizing cecal TMA as a nutrient.
- ZDY01 did not change the expression of hepatic FMO3 or the gut microbiota composition.
- The compound enhanced the expression of bile acid transporters and reduced cecal CDCA levels.
- ZDY01 attenuated the FXR/FGF15 pathway, leading to increased expression of Cyp7a1.
- These changes promoted reverse cholesterol transport.
AI simplified